Top Markets
Coin of the day
XORTX Therapeutics Inc. XORTX Therapeutics Inc.

XORTX Therapeutics Inc.

XRTX
Rangering i aksjer #39281
Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm... Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering and bringing to market treatments for a variety of conditions, including progressive kidney disorders, diabetes, insulin resistance, metabolic syndrome, and infections. The company's pipeline includes XRx-008, a late-stage clinical program addressing autosomal dominant polycystic kidney disease; XRx-101, an agent designed to reduce uric acid levels in COVID-19 patients to prevent acute kidney injury and its associated health issues; and XRx-221, a series of xanthine oxidase inhibitor candidates aimed at treating diabetic nephropathy. Furthermore, XORTX Therapeutics collaborates with the Icahn School of Medicine to research the occurrence of acute kidney injury and elevated uric acid in patients hospitalized with COVID-19.
Aksjekurs
$2.06
Sist synkronisert: 2026-08-11
Markedsverdi
$572.30K
Endring (1 dag)
0.00%
Endring (1 år)
-90.38%
Land
CA
Handel XORTX Therapeutics Inc. (XRTX)

Kategori

Historikk for aksjesplitt for XORTX Therapeutics Inc. (XRTX)
Aksjen XORTX Therapeutics Inc. (symbol: XRTX) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 14, 2026.
Én XRTX-aksje kjøpt før Aug 14, 2026 tilsvarer i dag 0 XRTX-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE